Optura, a Nashville, TN-based enterprise healthcare platform for ROAI™ (Return on AI Investment), has raised $17.5 million in Series A funding, bringing its total funding to over $25 million.
Investors
The round was led by Salesforce Ventures, with participation from Echo Health Ventures and continued backing from Susa Ventures, Matrix Partners, and HC9 Ventures.
Salesforce Ventures is the corporate venture capital (CVC) arm of Salesforce, the global cloud-based software company. Founded in 2009, it invests globally across the U.S., Europe, Israel, Japan, Korea, India, and Australia. Since its founding, the firm has deployed over $6 billion in capital into more than 630 startups. It focuses on enterprise software companies, investing from seed through growth stages.
Optura Use of Funds
The company will use the funding to expand its AI capabilities, grow teams, and scale partnerships with large language model (LLM) providers.
About Optura
Led by CEO Andy Fanning, Optura develops an enterprise healthcare AI platform focused on measuring and optimizing ROAI™ (Return on AI Investment) for healthcare organizations. The company’s ROAI™ platform maps fragmented organizational data into a unified knowledge layer, scores AI use cases based on operational readiness and business priorities, simulates projected returns, and deploys AI agents trained specifically for healthcare workflows. Headquartered in Nashville, Optura serves enterprise healthcare organizations, including Independence Blue Cross, Prime Therapeutics, and Ardent Health.
Funding Details
Company: Optura
Raised: $17.5M
Round: Series A
Funding Date: May 2026
Lead Investor: Salesforce Ventures
Additional Investors: Echo Health Ventures, Susa Ventures, Matrix Partners, HC9 Ventures
Company Website: https://optura.ai/
Software Category: Healthcare AI Governance & ROI Management Software
Source: https://www.prnewswire.com/news-releases/optura-secures-17-5-million-series-a-from-salesforce-ventures-and-echo-health-ventures-to-scale-its-roai-platform-302771590.html